Pacific Biosciences of California, Inc. (PACB) stock
PACBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$1.96−0.01 (-0.51%)
Close on Nov 13, 2026Market cap $609.23MP/E –Yield 0.00%
Pacific Biosciences of California enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Pacific Biosciences of California's enterprise value was $412.72M on Nov 11, 2026, against $401.64M a year earlier. Over the last 5 years it ranged from -$189.15M to $3.43B, with a median of $373.11M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $412.72M | +55.3% |
| 2025 | Dec 31, 2025 | $265.81M | +788.1% |
| 2024 | Dec 31, 2024 | $29.93M | -98.3% |
| 2023 | Dec 29, 2023 | $1.77B | +74.3% |
| 2022 | Dec 30, 2022 | $1.01B | -70.5% |
| 2021 | Dec 31, 2021 | $3.43B | -23.0% |
| 2020 | Dec 31, 2020 | $4.46B | +504.7% |
| 2019 | Dec 31, 2019 | $737.38M | -26.3% |
| 2018 | Dec 31, 2018 | $1.00B | +328.8% |
| 2017 | Dec 29, 2017 | $233.33M | -16.8% |
| 2016 | Dec 30, 2016 | $280.36M | -70.5% |
| 2015 | Dec 31, 2015 | $949.91M | +101.7% |
| 2014 | Dec 31, 2014 | $471.05M | +102.9% |
| 2013 | Dec 31, 2013 | $232.16M | – |
| 2012 | Dec 31, 2012 | -$21.10M | – |
| 2011 | Dec 30, 2011 | -$37.31M | – |
See a number that looks wrong?